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Background: Conveying contemporary treatment options for those at risk of sudden cardiac arrest 
(SCA) is challenging. The purpose of the present research was to evaluate the quality and usability 
of available patient educational tools relevant to SCA and its treatment options, such as implantable 
cardioverter defibrillators (ICDs). We hypothesized that this review would identify gaps in areas 
of information for the enhancement of patient education and decision-making materials.
Methods: We used a formal instrument to assess specific domains of content, development, 
and effectiveness of 18 available SCA and ICD educational tools. The multidisciplinary review 
panel included two electrophysiologists, two general cardiologists, a cardiac psychologist, 
a health services researcher, and a patient advocate.
Results: Of the 18 education tools, four were rated as “good, may need revisions, but sufficient 
for use”, 12 were rated as “marginal, needs revision prior to use”, and two were rated as “poor, 
inadequate for use”. None of the tools were rated as being of “very good” or “excellent” quality.
Conclusion: There appear to be opportunities to improve the quality and completeness of 
existing educational tools for patients with SCA and ICD. While many tools have been developed, 
they fall below current standards for supporting informed medical decision-making.
Keywords: decision-making, implantable cardioverter defibrillators, patient-centered outcomes 
research
Introduction
Advancements in the treatment of sudden cardiac arrest (SCA) have been impressive.1 
The ability of the implantable cardioverter defibrillator (ICD) to detect and treat 
potentially fatal arrhythmias demonstrates the power and potential of biomedical 
technology. However, ICD implantation requires regular device monitoring, avoidance 
of certain electronic or magnetic devices, and potential limitations on driving.2,3 
A number of risks are also associated with ICD implantation, such as inappropriate 
shocks, a potentially negative impact on quality of life, and psychological distress, 
such as anxiety, depressed mood, hypervigilance, and avoidance.1
Ideally, the decision regarding whether an ICD implantation is “right” for an 
individual at risk for SCA should be one shared between the patient and their doctor 
after both parties have received adequate information on the risks and benefits of 
the available technology.4 To facilitate this process, many organizations and device 
companies have developed educational tools for those at high risk for SCA and potential 
ICD therapy (see Table 1).2,3,5–19
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Table 1 Description of patient education tools related to sudden cardiac arrest
Developer and title of tool Shortened 
title
Use Web link Sponsor
Cardiosmart: Arrhythmias5 CS-Arr Arrhythmia and treatment 
education
http://www.cardiosmart.org/
HeartDisease/CTT.aspx?id=232
American College 
of Cardiology
Cardiosmart: Sudden Cardiac Death6 CS-SCD SCD Education and ICD 
advisement
http://www.cardiosmart.org/
HeartDisease/CTT.aspx?id=724
American College 
of Cardiology
Boston Scientific: Your Heart Health7 Bos-Sci Broad education on heart 
disease, risk, and treatment
http://www.bostonscientific.com/ 
your-heart-health/index.html
Boston Scientific
IMPROVE HF Heart Failure Therapy: 
Devices for Heart Failure Rhythm 
Problems8
IHF-HFT Education on devices http://www.improvehf.com/ Medtronic
IMPROVE HF Living with an Implantable 
Device for Heart Rhythm Management8
IHF-ICD Post-implant education http://www.improvehf.com/ Medtronic
IMPROVE HF Sudden Cardiac Arrest and 
How to Protect Yourself8
IHF-SCA ICD education for SCA http://www.improvehf.com/ Medtronic
Heart Rhythm Society: Apples and 
Oranges9
HRS-A&O SCA education http://www.hrsonline.org/News/ 
SCA-awareness/sca_research.cfm
Heart Rhythm 
Society
Heart Rhythm Society: Implantable 
Cardioverter Defibrillators (ICD)10
HRS-ICD ICD education http://www.hrsonline.org/PatientInfo/
Treatments/ICD/index.cfm
Heart Rhythm 
Society
Heart Rhythm Society: ICD Frequently 
Asked Questions11
HRS-ICD- 
FAQ
ICD and SCA education http://www.hrsonline.org/ 
PatientInfo/Treatments/ICD/ 
icd_faqs.cfm
Heart Rhythm 
Society
Heart Rhythm Society: 
Risk Assessment12
HRS-RA Risk assessment and 
education for SCA 
and treatment
http://ceondemand.org/hrs/ 
ram/splash.php
Heart Rhythm 
Society
Heart Rhythm Society: Treatment13 HRS-SCAT SCA treatment options http://www.hrsonline.org/ 
PatientInfo/Treatments/index.cfm
Heart Rhythm 
Society
Medmovie.com: Electrophysiology Media 
Library14
HRS-Media Broad cardiac educational 
library
http://www.medmovie.com/
mmdatabase/MediaPlayer.aspx? 
ClientID=13&TopicID=886
Heart Rhythm 
Society
National Coalition for Women with 
Heart Disease: Support for Women15
Women- 
Heart
Includes women-specific 
education and support
http://www.womenheart.org/
supportForWomen/livingHD/ 
index.cfm
National Coalition 
for Women with 
Heart Disease
SCA Prevention Medical Advisory 
Team – SCA Prevention Pathways and 
Tools: What are Arrhythmias?16,18
SCA-Arr Education on arrhythmias 
and treatments
http://links.lww.com/A1086 Medtronic
SCA Prevention Medical Advisory 
Team – SCA Prevention Pathways and 
Tools: Patient Discharge Contract16,19
SCA-PDC Patient care instructions 
post HF diagnosis
http://links.lww.com/A1084 Medtronic
SCA Prevention Medical Advisory 
Team – SCA Prevention Pathways and 
Tools: Pre-ICD (Implantable Cardioverter 
Defibrillator) Placement2,16
SCA-Pre- 
ICD
SCD, AED, and ICD 
education
http://links.lww.com/A1086 Medtronic
SCA Prevention Medical Advisory 
Team – SCA Prevention Pathways and 
Tools: Post-ICD (Implantable Cardioverter 
Defibrillator) Placement3,16
SCA-Post- 
ICD
Post ICD implant 
education
http://links.lww.com/A1086 Medtronic
SCA Prevention Medical Advisory 
Team – SCA Prevention Pathways and 
Tools: Caring for a Person with Heart 
Failure16,17
SCA-Care Heart failure education 
for patients and partners
http://links.lww.com/A1086 Medtronic
Abbreviations: AED, automated external defibrillator; HF, heart failure; ICD, implantable cardioverter defibrillator; SCA, sudden cardiac arrest; SCD, sudden cardiac 
death.
The primary aim of the Sudden Cardiac Arrest Thought 
Leadership Alliance (SCATLA), comprised of representatives 
of professional societies, academics, and patient advocacy 
groups, is to assist patients, families, and physicians, in 
making optimal treatment decisions for preventing SCA. 
The first step in realizing this goal is to understand the current 
status of patient education materials. Educational materials for 
patients undergoing cardiac surgery have been systematically 
evaluated.20 We are aware of only one study that evaluated 
ICD-related educational materials, and the primary objective 
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of this study was to determine the readability of various print 
materials by a broad audience.21
Our specific aims were to evaluate the available SCA 
and ICD education material in terms of breadth and depth of 
content, empirical development of the tool, and the potential 
effectiveness of the tool in assisting patients in decision-
making. To achieve this, a structured process was used to 
generate a template for evaluating the available tools. The 
goal of this evaluation was to identify gaps in the existing 
educational tools on SCA and ICD and propose means of 
enhancing educational tools related to SCA and ICD.
Materials and methods
Identification and evaluation 
of SCA and ICD education tools
The first phase of this project was identification of existing SCA 
patient education tools. We searched the Internet for patient 
education tools related to SCA and ICD therapy. Search terms 
included various combinations of the following: sudden cardiac 
arrest; implantable cardioverter defibrillator; treatment; education. 
We also reviewed the websites of major cardiology professional 
societies, patient advocacy groups, associations focused on SCA, 
and the major manufacturers of devices for SCA.
The second phase of the project involved implementation 
of an instrument to assess SCA-related education tools 
on the specific domains of content, development, and 
effectiveness.22,23 The instrument used in the current study 
included 16 questions derived from the 2005 International 
Patient Decision Aids Standards (IPDAS 2005) criteria for 
judging the quality of decision aids. The IPDAS criteria were 
developed from the work of the Cochrane Collaborative,22,23 
where content validity was established by identification of 
content by a panel of decision aid experts. Using the IPDAS 
instrument, we were able to examine SCA-related materials 
using a validated instrument that reflects the current standard 
for patient education materials.
The items in the instrument reflect the importance of 
a comprehensive and patient-centered approach toward 
educating individuals at risk for SCA (see Table 2). We 
placed each item on a rating scale ranging from 1 (very 
poor) to 6 (excellent) with the addition of a choice for “not 
applicable”. These 16 items comprised subscales related to 
content (six questions), development (five questions), and 
effectiveness (five questions).
In the third phase of the project, each educational tool 
was assessed by a panel of reviewers with a wide variety of 
expertise, including two electrophysiologists (SMA, KLT), 
two general cardiologists (GF, DH), a cardiac psychologist 
(SS), a health services researcher (GS), and a patient 
advocate with a master’s degree in public health (SC). 
These individuals were chosen to participate because of their 
experience in the treatment of patients with SCA, use of 
decision tools, and/or their nationally recognized expertise. 
Each of the reviewers responded to all the questions in the 
instrument for each of the educational tools. Reviewers 
could also make qualitative comments or suggestions 
regarding each tool. Tools were assessed on the basis of 
their individual qualities, even if they were part of a larger 
group of educational instruments.
Data analysis
Mean scores were calculated for each educational tool by 
total scores, subscale scores (ie, content, development, and 
effectiveness), and all individual item scores (total of 16). 
The total scores were divided by 16 (number of items in the 
full measure), and the subscales were divided by the number 
Table 2 Individual item evaluation
Ratio of tools with 
relatively better 
ratings ($3.5 rating)
Content items
 1.  Provide information about options, risks, 
benefits, financial impact, and alternatives 
in sufficient detail for decision-making?
13/18
 2.  Present probability of outcomes in an 
unbiased and understandable way?
7/18
 3.  Include information that reflects 
expectations for quality of daily life and 
long-term functional capacities?
15/18
 4.  Include methods for clarifying and 
expressing patient values?
13/18
 5.  Include attention to the effects of therapy 
on personal and family functioning?
6/18
 6.  Include structured guidance in 
deliberation and communication?
0/18
Development items
 7. Present information in a balanced manner? 15/18
 8. Has a systematic development process? 5/18
 9.  Use current scientific evidence that 
is cited in a reference section of the 
technical document?
7/18
10. Disclose conflicts of interest? 3/18*
11.  Use plain, accurate, culturally 
appropriate, and standardized language?
3/18
Effectiveness items
12.  Recognize a decision needs to be made 
and in what timeframe?
2/18
13.  Know action steps, options, and their 
features?
8/18
14. Understand that values affect decision? 6/18
15. Discuss values with their practitioners? 6/18
16.  Improve the match between the chosen 
option and the features that matter most 
to the informed patient?
2/18
Note: *All tools may not have had conflicts of interest to disclose.
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of items in each respective subscale. Items that were scored 
as “not applicable” by a particular reviewer were replaced 
using the average score of the other expert raters on the same 
item. Use of mean substitution with the other raters’ scores 
was considered the most conservative method because having 
a missing or zero score could negatively affect the rating 
of a particular tool. The maximum possible score for each 
question was 6. The following prespecified cut points were 
used for each question to interpret the results:
•	 means from 1 to 1.4 indicate very poor quality and 
inadequate for use
•	 means from 1.5 to 2.4 indicate poor quality and inad-
equate for use
•	 means from 2.5 to 3.4 indicate marginal quality and need 
for revision prior to use
•	 means from 3.5 to 4.4 indicate good quality and may need 
revisions but sufficient for use
•	 means from 4.5 to 5.4 indicate very good quality
•	 means above 5.5 indicate excellent quality.
In order to evaluate relative areas of strength and 
weakness among all 18 tools, we also examined how highly 
each of the 16 individual items was scored in each of the 
18 tools. To do this, average ratings of $3.5 on each item 
were considered to have received relatively strong scores. 
Any items with a mean rating of ,3.5 were considered to 
have received relatively poor ratings. A prespecified cutoff of 
3.5 was chosen because this is the halfway point on the 1–6 
rating scale. Next, the number of tools with relatively strong 
scores ($3.5 average rating) on each item the number of 
tools with relatively weak scores (#3.5 average rating) were 
tallied. The final statistic listed the number of tools out of the 
18 that had relatively strong or relatively weak scores.
Results
Our search conducted from December 2009 through March 
2011 yielded the 18 tools listed in Table 1. We included 
all the instruments found regardless of the source or who 
developed them. Of the tools included, two were developed 
by the American College of Cardiology,3,4 one by Boston 
Scientific,5 three by the IMPROVE Heart Failure Research 
Group,6 six by the Heart Rhythm Society,7–12 one by the 
National Coalition for Women with Heart Disease,13 and five 
by the SCA Prevention Medical Advisory Team.14–19
Inter-rater reliability (Kendall’s coeff icient of 
concordance) was significant between the seven raters 
[W = 0.45, χ2 (286, n = 7) =898.92, P , 0.001]. In terms of 
total score on the 18 education tools, four were rated as “good, 
may need revisions, but sufficient for use” and 12 were rated 
as “marginal, needs revision prior to use and two were rated 
poor, inadequate for use”. None of the tools were rated as 
having “very good” or “excellent” quality (see Table 2).
On the content subscale, five of the educational tools 
were rated as “good, may need revisions, but sufficient 
for use”, 12 were rated as “marginal, needs revision prior 
to use”, and two were rated as “poor, inadequate for use”. 
On the development subscale, eight of the education tools 
were rated as “good, may need revisions, but sufficient for 
use”, seven were rated as “marginal, needs revision prior 
to use”, and three were rated as “poor, inadequate for use”. 
On effectiveness, five educational tools were rated as “good, 
may need revisions, but sufficient for use”, eight were rated as 
“marginal, needs revision prior to use”, and four were rated as 
“poor, inadequate for use”. None were rated as having “very 
good” or “excellent” quality. These results are presented in 
Table 3 Eighteen patient education tools related to sudden 
cardiac arrest with subscale and total scores
Educational 
tool
Content Development Effectiveness Total
HRS-A&O 3.55* 3.71* 2.34 3.22
SCA-Care 2.20 2.37 1.74 2.11
HRS-RA 2.13 2.19 2.76 2.35
HRS-Media 2.96 3.14 3.43 3.16
HRS-ICD 3.11 3.49 3.11 3.23
HRS-ICD-FAQ 2.90 3.26 3.71* 3.26
HRS-SCAT 3.71* 3.71* 3.29 3.58*
Women-Heart 3.39 3.17 3.17 3.25
IHF-HFT 3.37 3.56* 3.55* 3.48
IHF-ICD 3.37 4.04* 3.64* 3.67*
SCA-PDC 3.66* 3.71* 3.74* 3.70*
SCA-Arr 3.98* 3.87* 3.67* 3.85*
SCA-Post-ICD 3.96* 3.55* 2.77 3.46
SCA-Pre-ICD 2.84 2.83 2.40 2.70
Bos-Sci 2.66 2.49 2.35 2.51
CS-Arr 3.02 2.75 2.87 2.89
CS-SCD 3.44 3.02 2.31 2.96
IHF-SCA 3.13 3.73* 2.80 3.21
Notes: All total and subscale scores were converted to a 1–6 rating scale (by 
dividing the total by the number of items) to allow for interpretation on the quality 
rating index (ie, very poor to excellent). *Indicates scores in the “good” range and 
higher.
Abbreviations: A&O, Apples and Oranges; SCA-Care, SCA Prevention Medical 
Advisory Team- SCA Prevention Pathways and Tools: Caring for a Person with 
Heart Failure; RA, Risk Assessment; HRS-Media, Medmovie.com: Electrophysiology 
Media Library; ICD, Implantable Cardioverter Defibrillators; FAQ, Frequently 
Asked Questions; HRS, Hearth Rhythm Society; SCAT, Treatment; Women-Heart, 
National Coalition  for Women with Heart Disease: Support for Women; IHF-
HFT, IMPROVE HF Heart Failure Therapy; IHF-ICD, IMPROVE HF Living with an 
Implantable Device for Heart Rhythm Management; SCA-PDC, SCA Prevention 
Medical Advisory Team-SCA Prevention Pathways and Tools: Patient Discharge 
Contract; SCA-Arr, Prevention  Medical Advisory Team- SCA Prevention Pathways 
and Tools: What are Arrhythmias?; SCA-Post-ICD, SCA Prevention Medical 
Advisory Team-  SCA Prevention Pathways and Tools: Post-ICD Placement; SCA-
Pre-ICD, SCA Prevention Medical Advisory Team- SCA Prevention Pathways and 
Tools: Pre-ICD Placement; Bas-Sci, Boston Scientific: Your Heart Health; CS-Arr, 
Cardiosmart: Arrhythmias; CS-SCD, Cardiosmart: Sudden Cardiac Death; IHF-SCA, 
IMPROVE HF Sudden Cardiac Arrest and How to Protect Yourself
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Table 3. In each of the areas of content, development, and 
effectiveness, none of the tools were rated as having “very 
good” or “excellent” quality.
Each particular item in the 18 tools was examined 
individually to determine how well it was addressed. Of 
the items on the content subscale, those that were addressed 
well included: provides information about options, risks, 
benefits, financial impact, and alternatives in sufficient 
detail for decision-making; includes information that reflects 
expectations for quality of daily life and long-term functional 
capacities; and includes methods for clarifying and expressing 
patients’ values. Items that were addressed poorly or not 
included at all: includes attention to the effects of therapy on 
personal and family functioning; and presents probability of 
outcomes in an unbiased and understandable way.
The development subscale item best addressed by the 
tools was: presents information in a balanced manner. The 
other items on the development subscale scored relatively 
poorly and included the following: has a systematic 
development process; uses current scientific evidence that 
is cited in the reference section of the technical document; 
discloses conflicts of interest; and uses plain, accurate, 
culturally appropriate, and standardized language.
With regard to individual item ratings on the effectiveness 
subscale, none of the items were well addressed by most of 
the tools. The tools generally scored poorly on their ratings 
to provide information effectively so that a consumer could 
do the following: recognize that a timely decision needs to 
be made; be familiar with the action steps, options, and their 
features; understand that values affect decision-making; 
discuss values with their practitioners; and improve the match 
between the chosen option and the features that matter most 
to the informed patient. The results of the individual item 
analysis are presented in Table 2.
The two educational tools that scored highest in our 
review overall were the SCA-PDC tool and the SCA-Arr 
tool. The SCA-PDC tool scored a mean of 3.66 on the content 
subscale, 3.71 on the development subscale, and 3.74 on the 
effectiveness subscale, and had a 3.70 total scale score. This 
measure was rated in the “very good” range for its ability 
to “present information in a balanced manner”. However, 
this measure also scored in the “marginal quality and in 
need of revision prior to use” range on the following items: 
provides information about options, risks, benefits, financial 
impact, and alternatives in sufficient detail for decision-
making; includes structured guidance in deliberation and 
communication; discloses conflicts of interest; uses plain, 
accurate, culturally appropriate, and standardized language; 
and recognizes a decision needs to be made and with a certain 
timetable.
The SCA-Arr tool scored a mean of 3.98 on the content 
subscale, 3.87 on the development subscale, and 3.67 on 
the effectiveness subscale, and had a 3.85 total scale score. 
The tool scored in the “very good” range on the following 
items: presents information in a balanced manner; uses 
current scientific evidence with citations listed; includes 
methods for clarifying and expressing patient values; and 
includes attention to the effects of therapy on personal and 
family functioning. However, this measure also scored in 
the “marginal quality and in need of revision prior to use” 
range on the following items: includes structured guidance 
in deliberation and communication; uses plain, accurate, 
culturally appropriate, and standardized language; recognizes 
a decision needs to be made and with a certain timeframe; 
and improves the match between the chosen option and the 
features that matter most to the informed patient.
Discussion
SCA is the most common mode of death in the United States, 
claiming the lives of more than 300,000 people each year.24 
To reduce the morbidity and mortality associated with SCA, 
it is critically important to educate patients about SCA and the 
therapies that have been proven to reduce risk. While many 
patient educational tools have been developed, they vary in 
form and quality. To our knowledge, this is the first study 
to evaluate areas of development, content, and effectiveness 
for existing patient education tools on SCA in a systematic 
way. Our review found that none of the existing tools met our 
predefined optimal criteria in terms of content, development, 
and effectiveness domains. However, four tools had total 
scores in the “good, may need revisions, but sufficient 
for use” range (ie, HRS-SCAT, IHF-ICD, SCA-PDC, and 
SCA-Arr). Only two of these tools were considered “good, 
may need revisions, but sufficient for use” (ie, SCA-PDC 
and SCA-Arr) in all three of the major domains of content, 
development, and effectiveness. None of the tools were 
considered to be very good or excellent in quality. Also, 
none of the education tools scored in the good quality range 
or higher on all of the 16 individual survey items, suggesting 
at least some need for revision in every tool assessed.
The purpose of this research was to identify gaps in the 
current education tools that could be addressed to enhance the 
value and potential effectiveness of such tools. We explored 
each of the individual items and identified some which were 
consistently rated highly among a majority of the tools; 
however, many of the items in the tools consistently received 
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poor ratings. Lack of content information related to the 
probabilities of outcomes in unbiased and understandable 
ways, limited attention paid to the effects of therapy on 
personal and family functioning, and lack of structured 
guidance on deliberation and communication were the items 
most cited.
While the majority of tools appeared to present 
information in a balanced manner, most were lacking 
in systematic development, citation of current scientific 
evidence used by the tool, disclosure of relevant conflicts 
of interest, and use of suitable language. The effectiveness 
of the tools appeared to be weak for all items assessed. 
The tools generally scored poorly on helping patients to 
recognize that a timely decision needs to be made, knowing 
action steps and options, understanding that values affect 
decisions, understanding the importance of discussing values 
with their health practitioners, and choosing an option that 
matters most to the informed patient. Future tools should 
focus on developing materials that address all the identified 
deficits.
Limitations
There are a number of limitations to this review process to 
consider. While the overall quality rating of the instruments 
examined in this study may be somewhat discouraging, 
evaluation of these tools was completed using criteria that 
were not available to the creators. In addition, the tools were 
assessed on their individual strengths and weaknesses, although 
it may have been a more appropriate strategy to assess each 
set of tools by the individual device units created by each 
developer or organization. The feasibility of analyzing sets 
of tools was limited by the fact that the instruments often 
repeated information, were developed as separate educational 
units, and the length of the combined material would have 
made the analysis more complex, potentially limiting each 
reviewer’s ability to make judgments. In other words, the broad 
range of information would have created a large amount of 
information that would have been difficult to assess together. 
Although we used an existing method for assessing the quality 
of these educational tools, we also selected the evaluating 
criteria. We had limited reviewers who were not blinded to 
the makers of the tools, although there was a high degree of 
inter-rater reliability. The rating system was subjective, but was 
prospectively defined. Not including information available from 
some websites, such as those from various cardiology groups, 
was another limitation. There may be excellent tools that exist 
which we did not assess. Further, we did not assess the reading 
level of the educational material, in that our reviewers rated the 
tools based on the criteria: “does the tool use plain, accurate, 
culturally appropriate, and standardized language?” While this 
“language” criterion was drawn from the IPDAS 2005 criteria 
for judging the quality of decision aids,23,24 making the desired 
reading level known to the reviewers may have improved their 
assessment of these criteria. Despite these potential limitations, 
our goal of identifying improvements needed in future SCA 
and ICD educational tools was achieved.
Future directions
Future work will focus on development of tools that provide 
educational information to patients and their loved ones to 
promote learning and guide decision-making in a patient-
centered framework. The focus will be on understanding 
heart disease, the risk of SCA, and treatment options, 
a second focus will be on understanding heart failure, and a 
third focus will be on caring for a person with heart disease. 
These educational tools to address the deficits identified this 
study. Our tools provide information on content and place, 
and emphasis on helping patients make informed decisions 
about their treatment. Realizing that major domains related 
to content were generally well represented among the tools, 
efforts were made to ensure that the most relevant information 
was provided in the most systematic manner. We also focused 
on patient decision-making by providing as much directive 
information as possible and described treatments concisely. 
These tools will be tested for their effect on patient outcomes, 
including quality of life, satisfaction with decisions made, 
and any ensuing psychological distress.
Conclusion
While the tools in this study could be considered well 
designed by previous standards, none of the existing SCA-
related educational tools evaluated in our study met all the 
criteria for an empirically developed, content-appropriate, 
and effective educational tool. The primary deficit that 
reviewers noted was the potential effectiveness of the tools. 
Specific gaps were identified in: structured guidance in 
deliberation and communication; use of plain, accurate, 
culturally appropriate, and standardized language; helping 
patients recognize that a decision needs to be made in a 
certain timeframe; and helping patients by improving the 
match between the chosen option and the features that matter 
most to the informed patient. Using this information, the 
SCATLA has developed three education tools that will be 
pilot-tested and later disseminated to the public to enhance 
patient understanding of SCA and its therapies and to 
facilitate informed decision-making.
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